Tag

Breast Cancer

All articles tagged with #breast cancer

Miracle Pregnancy Turns into Race Against Seven Brain Tumors
health4 days ago

Miracle Pregnancy Turns into Race Against Seven Brain Tumors

A 34-year-old UK mom who conceived a “miracle” baby after breast-cancer treatment is later diagnosed with stage-4 brain cancer featuring seven tumors. She’ll have an emergency C-section at 31 weeks to begin chemotherapy and radiation, with doctors hopeful for the baby’s health. Carroll says the pregnancy saved her life by alerting her to cancer earlier, but she’s anxious about treatment side effects and the impact on her ability to be with her newborn and her other children.

GLP-1 Drugs Show Systemic Effects Beyond Weight Loss in June 2026 Studies
health9 days ago

GLP-1 Drugs Show Systemic Effects Beyond Weight Loss in June 2026 Studies

Four observational studies published in June 2026 suggest GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) may affect more than glucose and weight: roughly 30% lower odds of breast cancer in users, a weakened impulsivity-to-violence link linked to brain GLP-1 receptors, a possible bone-protective effect despite weight loss, and a significant drop in daily physical activity among users. None establish causation; findings require randomized trials and do not change current indications. Clinicians should emphasize exercise and bone health monitoring, and patients should not start/stop meds based on these early results. Larger prospective studies are needed to confirm these associations.

GLP-1 Drugs May Slow Metastasis in Obesity-Related Cancers, Early ASCO Data
health10 days ago

GLP-1 Drugs May Slow Metastasis in Obesity-Related Cancers, Early ASCO Data

Real-world TriNetX data presented at ASCO 2026 show GLP-1 receptor agonists used after cancer diagnosis linked to reduced metastatic progression across several obesity-related cancers, notably NSCLC, breast, colorectal, and hepatocellular carcinoma; in NSCLC, progression to stage IV was 10.0% with GLP-1 RAs vs 22.3% with DPP-4 inhibitors (HR 0.50). GLP-1 receptor expression also correlated with better overall survival, suggesting a potential class effect and the need for further study.

GLP-1 Weight Drugs May Lower Cancer Risk, But More Proof Is Needed
health10 days ago

GLP-1 Weight Drugs May Lower Cancer Risk, But More Proof Is Needed

Early observational studies link GLP-1 receptor agonists—widely used for diabetes and weight loss—with a lower risk of several obesity-related cancers, including breast cancer, with a Penn Medicine study showing a 30–35% lower incidence in users; the proposed benefits may come from weight loss, reduced inflammation, improved insulin sensitivity, and lower estrogen after menopause, and possibly direct anti-cancer effects. However, these findings are not from randomized trials and GLP-1s are not FDA-approved for cancer prevention; safety concerns like medullary thyroid carcinoma warning exist, so for now cancer prevention relies on established screenings and managing metabolic health, with any future preventive use limited to high-risk patients under supervision.

Essex woman urges self-referral mammograms for over-70s following cancer diagnosis
health12 days ago

Essex woman urges self-referral mammograms for over-70s following cancer diagnosis

A 79-year-old Essex woman, Carol Turansky, found breast cancer after arranging a self-referred mammogram and now urges other women over 70 to self-refer for routine screening. She argues the NHS should educate older women about this option, as current invitations target ages 50–70. Her petition has over 70,000 signatures. Health authorities say screening benefits and risks vary by age and that overdiagnosis rises with age, but screening remains important if changes are noticed, with trials looking at extending access beyond current ages. Turansky faces a mastectomy.

Robot-Assisted Nipple-Sparing Mastectomy Makes US Milestone
health14 days ago

Robot-Assisted Nipple-Sparing Mastectomy Makes US Milestone

A California mom with triple-negative breast cancer underwent the United States’ first robotic single-port nipple-sparing mastectomy outside clinical trials, using a $2 million Da Vinci SP robot named Carol at Sutter Health’s Alta Bates Summit Medical Center. The procedure preserves the nipple and skin through a tiny initial incision and 3D magnified vision, with the surgeon in full control. The FDA has cleared the robot for nipple-sparing mastectomies, signaling broader adoption as more centers train. Pan is now in remission but continues chemotherapy and immunotherapy to prevent recurrence and will need reconstructive surgery, marking a hopeful milestone in cancer care and surgical technology.

Mt. Lebanon Man Battles Rare Male Breast Cancer and Raises Awareness
health22 days ago

Mt. Lebanon Man Battles Rare Male Breast Cancer and Raises Awareness

George Banky, a 62-year-old from Mt. Lebanon, was diagnosed with breast cancer in 2025—rare for men (about 1 in 1,000). After a lump prompted surgery with negative lymph nodes, he’ll take Tamoxifen for five years and has begun speaking publicly to raise awareness and funds for male breast cancer, emphasizing that men don’t undergo routine screening and early evaluation is crucial; genetic testing is advised since hereditary factors can play a larger role in male cases.

AI Screening Could Detect Breast Cancer Signs Up to Six Years Early, Massive Swedish Study Finds
health25 days ago

AI Screening Could Detect Breast Cancer Signs Up to Six Years Early, Massive Swedish Study Finds

A Swedish study of 88,963 mammograms from over 31,000 women shows AI-based screening can flag mammographic signs of breast cancer years before radiologists diagnose it, with higher AI scores in those later diagnosed. The three AI-CAD systems achieved about 90% specificity and identified cancers six years before diagnosis in ~20% of participants, four years prior in ~25%, and two years prior in ~40%, suggesting AI could enable earlier intervention.

Sabretooth Actor Tyler Mane Battles Rare Male Breast Cancer, Begins Chemo
entertainment1 month ago

Sabretooth Actor Tyler Mane Battles Rare Male Breast Cancer, Begins Chemo

Tyler Mane, known for playing Sabretooth in X-Men and Michael Myers in Rob Zombie’s Halloween remakes, revealed on Instagram that he has breast cancer—the rarest form for men (about 1% of cases)—and has begun chemotherapy. He aims to document the journey to raise awareness and encourage early detection, noting his wife prompted him to seek treatment after a lump was found.

Chemo to Clicks: The Double Life of a Cancer Influencer
health1 month ago

Chemo to Clicks: The Double Life of a Cancer Influencer

Diagnosed with breast cancer at 35 in 2023, Sarah Barness began documenting her treatment on Patreon, tapping into the cancer-influencer ecosystem, and grew a subscriber base that provided nearly $1,000/month during active therapy. But as hair regrew and treatment ended, engagement waned, forcing her to confront being ‘invisible’ and navigate the ongoing realities of cancer beyond visible symptoms, a tension echoed by other young survivors about authenticity, community, and monetization in illness content.

X-Men star Tyler Mane reveals rare male breast cancer, starts chemotherapy
entertainment1 month ago

X-Men star Tyler Mane reveals rare male breast cancer, starts chemotherapy

Tyler Mane, who played Sabretooth in the 2000 X-Men film, announced on Instagram that he has been diagnosed with a rare form of breast cancer and has begun chemotherapy. He notes that men are often diagnosed late because the disease is rarely discussed for men, citing CDC figures that about 1% of breast cancers occur in men and that roughly one in 750 men will be diagnosed in a lifetime. Mane says he initially faced misdiagnosis but his wife encouraged him to seek treatment, and he’s using his platform to raise awareness and encourage early detection.

Massachusetts investigates breast cancer cluster among Uxbridge High School teachers
health1 month ago

Massachusetts investigates breast cancer cluster among Uxbridge High School teachers

Massachusetts health officials have launched an investigation into multiple breast cancer diagnoses among teachers at Uxbridge High School. The state Department of Public Health will visit the school to conduct extensive testing—including air quality and building-system reviews—and will look into the medical and genetic histories of the affected teachers to assess common causes, while noting there is no evidence of immediate danger or need to restrict access. Experts say a direct link to the school is unlikely, as breast cancers are often linked to factors like smoking and alcohol rather than rare chemical exposures.

GLP-1 Weight-Loss Drugs Linked to Lower Breast Cancer Risk, Prompting New Trials
health1 month ago

GLP-1 Weight-Loss Drugs Linked to Lower Breast Cancer Risk, Prompting New Trials

New observational studies presented at ASCO suggest GLP-1 medications used for diabetes and weight loss (e.g., semaglutide, liraglutide) are associated with a lower incidence of breast cancer and, among those diagnosed, reduced progression and mortality. While promising, the studies cannot prove causation, and researchers are planning randomized trials to test whether GLP-1 drugs can help prevent breast cancer or improve outcomes in high-risk individuals.